Role of inflammation and tumor microenvironment in the development of gastrointestinal cancers: What induced pluripotent stem cells can do?

Current Stem Cell Research and Therapy

Volumn 10, Issue 3, 2015, Pages 245-250

  Zhang, Lei ^a   Song, Xiaojing ^a   Mohri, Yasuhiko ^b   Qiao, Liang ^c  

^a LANZHOU UNIVERSITY   (China)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cytokines; Gastrointestinal cancer; Inflammation; IPSCs; Tumor microenvironment

Indexed keywords

CHEMOKINE; CYTOKINE; HIGH MOBILITY GROUP B PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; KRUPPEL LIKE FACTOR 4; MACROPHAGE MIGRATION INHIBITION FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; DIGESTIVE SYSTEM CANCER; EXTRACELLULAR MATRIX; HEMATOPOIETIC CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; MAST CELL; META ANALYSIS (TOPIC); METASTASIS; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WNT SIGNALING PATHWAY; ANIMAL; CANCER STEM CELL; COMPLICATION; CYTOLOGY; GASTROINTESTINAL NEOPLASMS; PATHOLOGY; STEM CELL TRANSPLANTATION;

ANIMALS; CELLULAR REPROGRAMMING; GASTROINTESTINAL NEOPLASMS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFLAMMATION; NEOPLASTIC STEM CELLS; STEM CELL TRANSPLANTATION; TUMOR MICROENVIRONMENT;

EID: 84928949325     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X09666140812112305     Document Type: Article

References (72)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-7.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-741.
3. Ancrile B, Lim KH, Counter CM. Oncogenic Ras-induced serection of IL6 is required for tumorigenesis. Gene Dev 2007; 21: 1714-9.
4. Borrello MG, Alberti L, Fischer A, et al.Induction of a proinflammatory program in normal human thyrocytes by the RET/PIC1 oncogene. Proc Natl Acad Sci USA 2005; 102: 14825-30.
5. Alban S, Fan J, Martindale JL, et al.von Hippel-Lindau proteinmediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays. Mol Cell Biol 2003; 23: 2316-28.
6. Allavena P, Mantovani A. Immunology in the clinic review series: focus on cancer: tumour-associated macrophages: undisrupted stars of the inflammatory tumour microenvironment. Clin Exp Immunol 2012; 167: 195-205.
7. Mantovani A, Allavena P, Sica A, et al.Cancer-related inflammation. Nature 2008; 454: 436-44.
8. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007; 121: 2373-80.
9. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7: 211-7.
10. de Visser KE, Eichten A, Coussenes LM. Paradoxical role of the immune system during cancer development. Nat Rev Cancer 2006; 6: 24-37.
11. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124: 823-35.
12. Yeh JM, Goldie SJ, Kuntz KM, et al.Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections, Cancer Causes Control 2009; 20: 2021-9.
13. Piao Y, Liu Z, Ding Z, et al.EGF+61A>G polymorphism and gastrointestinal cancer risk: A HuGE review and meta-analysis. Gene 2013; 519: 26-33.
14. Wilson GS, George J. Physical and chemical insults induce inflammation and gastrointestinal cancers. Cancer Lett 2014; 345: 190-5.
15. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect. 2009; 15: 971-6.
16. Fukayama M, Hino R, Uozaki H. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci 2008; 99: 1726-33.
17. Iizasa H, Nanbo A, Nishikawa J, et al.Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses 2012; 4: 3420-39.
18. Madar S, Goldstein I, Rotter V. ‘Cancer associated fibroblasts’– more than meets the eye. Trends Mol Med 2013; 19: 447-53.
19. Weber CE, Kuo PC. The tumor microenvironment. Surg Oncol 2012; 21: 172-177.
20. Quante M, Varga J, Wang TC, et al.The Gastrointestinal Tumor Microenvironment. Gastroenterology 2013; 145: 63-78.
21. Mantovani A, Bottazzi F, Colotta F, et al.The origin and function of tumor-associated macrophages. Immunol Today 1992; 13: 265-70.
22. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 6: 2591-9.
23. Coussens LM, Tinkle CL, Hanahan D, et al.MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103: 481-90.
24. Mantovani A, Sica A. Macrophages, Innate Immunity and cancer: balance, torelance, and diversity. Curr Opin Immunol 2010; 22: 231-7.
25. Biswas SK, Gangi L, Paul S, et al.A direct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 2006; 107: 2112-22.
26. Ojalvo LS, King W, Cox D, et al.High-densing gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am J Pathol 2009; 174: 1048-64.
27. Pucci F, Venneri MA, Biziato D, et al.A distinguishing gene signature shared by tumor-infiltrating Tie-2-expressing monocytes, blood “resident” monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 2009; 114: 901-14.
28. Ojalvo LS, Whittaker CA, Condeelis JS, et al.Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary manmmary tumors. J Immunol 2010; 184: 702-12.
29. Zhang QW, Liu L, Gong CY, et al.Prognostic significance of tumor-associated macrophages in solid tumors: a meta-analysis of the literature. PLoS One 2012; 7: e50946.
30. Behnes CL, Bremmer F, Hemmerlein B, et al.Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma. Virchows Arch 2014; 464: 191-6.
31. Qing W, Fang WY, Ye L, et al.Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma. Thyroid 2012; 22: 905-10.
32. Koong AC, Denko NC, Hudson KM, et al.Candidate genes for hypoxic tumor phenotype. Cancer Res 2000; 60: 883-7.
33. Guthrie GJ, Roxburgh CS, Horgan PG, et al.Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Cancer Treat Rev 2013; 39: 89-96.
34. Sansone P, Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 2012; 20: 1005-14.
35. Neurath MF, Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 2011; 22: 83-9.
36. Mudter J, Amoussina L, Schenk M, et al.The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. J Clin Invest 2008; 118: 2415-26.
37. Greten FR, Eckmann L, Greten TF, et al.IKK links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-96.
38. Naugler WE, Sakurai T, Kim S, et al.Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 121-4.
39. Dai Y, Jiao H, Teng G, et al.Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling. Mol Cancer Ther 2014; 13: 1206-16.
40. Weigmann B, Lehr HA, Yancopoulos G, et al.The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. J Exp Med 2008; 205: 2099-110.
41. Hong DS, Angelo LS, Kurzrock R. Interleukin-6 and its receptor in cancer: implications for translational therapies. Cancer 2007; 110: 1911-28.
42. Kinoshita T, Ito H, Miki C. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer 1999; 85: 2526-31.
43. Maihöfner C, Charalambous MP, Bhambra U, et al.Colorectal Cancer Group. Expression of cyclooxygenase-2 parallels expression of interleukin-1 beta, interleukin-6 and NF-B in human colorectal cancer. Carcinogenesis 2003; 24: 665-71.
44. Chung YC, Chaen YL, Hsu CP. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma. Anticancer Res 2006; 26: 3905-11.
45. Mitchell RA. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 2004; 16: 13-9.
46. Wilson JM, Coletta PL, Cuthbert RJ, et al.Macrophage migration inhibitory factor promotes intestinal tumorigenesis, Gastroenterology 2005; 129: 1485-503.
47. He XX, Yang J, Ding YW, et al.Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potentioal role of MIF in gastric carcinogenesis. Gut 2006; 55: 797-802.
48. Ren Y, Law S, Huang X, et al.Macrophage migration inhibitory factor stimulates angiogeneic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg 2005; 242: 55-63.
49. Fingerle-Rowson GI, Petrenko O. MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models. Cell Div 2007; 2: 22.
50. Tan L, Ye X, Zhou Y, et al.Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of -cell. J Transl Med 2014; 12: 92.
51. Zhang L, Ye SB, Ma G, et al.The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma. J Transl Med 2013; 11: 60.
52. He XX, Chen K, Yang J, et al.Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med 2009; 15: 1-10.
53. Fodde R, Brabletz T. Wnt/-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007; 19: 150-8.
54. Oguma K, Ohshima H, Aoki M, et al.Activated macrophage promote Wnt signaling through tumour necrosis factor-in gastric tumour cells. EMBO J 2008; 27: 1671-81.
55. Smith K, Bui TD, Poulsom R, et al.Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br J Cancer 1999; 91: 496-502.
56. DeNardo DG1, Johansson M, Coussens LM. Inflaming gastrointestinal oncogenic programming. Cancer Cell 2008; 14: 7-9.
57. Haraguchi NUtsunomiya TInoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006; 24: 506-13.
58. Dalerba P, Dylla SJ, Park IK, et al.Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-63.
59. Du L, Wang H, He L, et al.CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008; 14: 6751-60.
60. Shmelkov SV, Butler JM, Hooper AT, et al.CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118: 2111-20.
61. Yang ZF, Ngai P, Ho DW, et al.Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008; 47: 919-28.
62. Chiba T, Kita K, Zheng YW, et al.Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006; 44: 240-51.
63. Yamashita T, Ji J, Budhu A, et al.EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009; 136: 1012-24.
64. Li C1, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells. Methods Mol Biol 2009; 568: 161-73.
65. Gurdon, JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 1962; 10: 622-40.
66. Wilmut I, Schnieke AE, McWhir J, et al.Viable offspring derived from fetal and adult mammalian cells. Nature 1997; 385: 810-3.
67. Takahashi K, Tanabe K, Ohnuki M, et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
68. Espejel S, Roll GR, McLaughlin KJ, et al.Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest 2010; 120: 3120-6.
69. Takebe T, Zhang RR, Koike H, et al.Generation of a vascularised and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc 2014; 9: 396-409.
70. Rashid ST, Corbineau S, Hannan N, et al.Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 2010; 120: 3127-36.
71. Miyoshi N, Ishii H, Nagai K, et al.Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci USA 2010; 107: 40-5.
72. Takaishi SI, Okumura T, Wang TC. Gastric cancer stem cells. J Clin Oncol 2008; 26: 2876-82.